Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT07735897
What this trial is testing

Long Term Cohort Study of Adding Ovarian Function Suppression to Tamoxifen in Young Women

Who this might be right for
Breast Cancer
MedicalExcellence 1,483
Testing effectiveness (Phase 2)Active Not RecruitingNCT04802161
What this trial is testing

Comparing the Addition of an Anti-Cancer Drug, Pomalidomide, to the Usual Chemotherapy Treatment (Daunorubicin and Cytarabine Liposome) in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Post Cytotoxic TherapyAcute Myeloid Leukemia With Multilineage Dysplasia+3 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT01612741
What this trial is testing

Diabetes Treatment With Glucobay in Combination With Metformin

Who this might be right for
Type 2 Diabetes Mellitus
Bayer 19,509
Not applicableStudy completedNCT00713141
What this trial is testing

Evaluation of Brain Function Before and After Standard Chemotherapy for Early Breast Cancer

Who this might be right for
Early Breast Cancer
National University Hospital, Singapore 30
Large-scale testing (Phase 3)Study completedNCT02329860
What this trial is testing

Study of Apatinib After Systemic Therapy in Patients With Hepatocellular Carcinoma(AHELP)

Who this might be right for
Carcinoma, Hepatocellular
Jiangsu HengRui Medicine Co., Ltd. 400
Testing effectiveness (Phase 2)Ended earlyNCT03737123
What this trial is testing

Trial of Atezolizumab Plus Chemotherapy After Progression on PD-1 or PD-L1 in Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Nabil Adra 6
Testing effectiveness (Phase 2)Study completedNCT02684461
What this trial is testing

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Who this might be right for
Non Small Cell Lung Cancer
UNC Lineberger Comprehensive Cancer Center 20
Large-scale testing (Phase 3)UnknownNCT01566942
What this trial is testing

FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 200
Testing effectiveness (Phase 2)Study completedNCT01446562
What this trial is testing

Y90 Ibritumomab Tiuxetan Post R-CHOP Chemotherapy for Advanced Stage Follicular Lymphoma

Who this might be right for
Follicular Lymphoma
Sunnybrook Health Sciences Centre 34
Early research (Phase 1)UnknownNCT02169388
What this trial is testing

Intestinal Microflora in Colorectal Cancer (CRC) After Chemotherapy

Who this might be right for
Gastrointestinal NeoplasmsColorectal CancerEffects of Chemotherapy+2 more
Shandong University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688291
What this trial is testing

A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy

Who this might be right for
Esophageal Squamous Carcinoma Cell
Beijing GoBroad Hospital 40
Large-scale testing (Phase 3)Looking for participantsNCT05080010
What this trial is testing

Adjuvant Chemotherapy for High-risk Postenucleation Retinoblastoma

Who this might be right for
Retinoblastoma
Sun Yat-sen University 500
Not applicableStudy completedNCT01719562
What this trial is testing

MRI in Detecting Heart Damage in Patients With Cancer Receiving Chemotherapy With Exercise Capacity Addendum

Who this might be right for
Cardiac ToxicityMalignant NeoplasmBreast Cancer
Wake Forest University Health Sciences 28
Testing effectiveness (Phase 2)UnknownNCT03781869
What this trial is testing

Study of Anlotinib as the Maintenance Therapy for Extensive-stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Third Military Medical University 116
Testing effectiveness (Phase 2)Looking for participantsNCT05024097
What this trial is testing

A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.

Who this might be right for
Rectal Cancer
Weill Medical College of Cornell University 43
Large-scale testing (Phase 3)Ended earlyNCT03158610
What this trial is testing

Biological-guided Metronomic Chemotherapy as Maintenance Strategy in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Ruijin Hospital 20
Not applicableNot Yet RecruitingNCT07622407
What this trial is testing

Maximizing Quality of Life After Cancer Through Rehabilitation

Who this might be right for
Head and Neck CancerHearing LossTinnitus+1 more
VA Office of Research and Development 74
Testing effectiveness (Phase 2)Looking for participantsNCT07167160
What this trial is testing

Chemo-immunotherapy for Cervical Cancer Stage IIICp Trial

Who this might be right for
Cervical CancerImmunochemotherapy
Women's Hospital School Of Medicine Zhejiang University 59
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05979220
What this trial is testing

Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy

Who this might be right for
Breast Cancer
Shuangyue Liu 178
Not applicableUnknownNCT02597868
What this trial is testing

A Multicenter, Randomized Clinical Trail Evaluate Effectiveness and Security of Capecitabine or Endocrinotherapy as a Maintenance Therapy Regimen After the 1st-line Chemotherapy With Capecitabine Combine Regimen in Hormone Receptor Positive and HER2 Negative Metastatic Breast Cancer(Overstep)

Who this might be right for
Breast Cancer
Zhejiang Cancer Hospital 132
Next Page
49